News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Almon Einat Brill
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2020 |
4
| Almon Einat Brill (SVP, Chief Development Officer) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 196,995 options to buy
@ $3.59, valued at
$707.2k
|
|
| 09/14/2018 |
4
| Almon Einat Brill (SVP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 700,000 options to buy
@ $0.56, valued at
$392k
|
|
| 05/07/2015 |
4
| Almon Einat Brill (SVP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.72, valued at
$430k
|
|
| 07/18/2012 |
4
| Almon Einat Brill (SVP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 185,000 shares
@ $0 |
|
| 05/04/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2010 |
4
| Almon Einat Brill (VP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $6.9, valued at
$897k
|
|
| 10/19/2009 |
4
| Almon Einat Brill (VP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
| 07/08/2009 |
4
| Almon Einat Brill (VP, Product Development) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
| 05/19/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|